Degenerative diseases are characterized by a worsening of disease status ov
er time. The rate of deterioration is determined by the natural rate of pro
gression of the disease and by the effect of drug treatments. A goal of dru
g treatment is to slow disease progression. Drug treatments can be categori
zed as symptomatic or protective. Symptomatic treatments do not affect the
rate of disease progression whereas protective treatments have the ability
to slow disease progression down. Many current methods for describing disea
se progression have two common drawbacks: a linear relationship between tim
e and disease status is assumed, and within- and between-subject variabilit
y is ignored. Disease progress models combined with pharmacokinetic-pharmac
odynamic models and hierarchical random effects statistical models provide
insights into understanding the time course and management of degenerative
disease.